BRCA2 and medulloblastoma: A recent study including 1022 medulloblastoma patients found that 6% of all cases had a germline mutation in TP53, APC, PTCH1, SUFU, or in two additional genes with presumed tumor suppressor function: BRCA2 or PALB2 [3].